Publication | Closed Access

Phase IIa/IIb clinical trial of NC-6004 (Nanoparticle Cisplatin) plus Pembrolizumab in patients with head and neck cancer (HNSCC) who have failed platinum or a platinum-containing regimen

Platinum-containing RegimenNeck CancerMedicineClinical TrialsHead And Neck CancerNanoparticle CisplatinCancer TreatmentNeck OncologyOncologyRadiation OncologyHealth Sciences